APA

Eagleton M. J., Bishop P. D., Bena J. F., Nassoiy S. P., Clair D. G., Kashyap V. S. & Ouriel K. (20090917). Calcium channel blockers and angiotensin-converting enzyme inhibitors may be associated with altered atherosclerotic plaque size and morphology. : Vascular.

Chicago

Eagleton Matthew J, Bishop Paul D, Bena James F, Nassoiy Sean P, Clair Daniel G, Kashyap Vikram S and Ouriel Kenneth. 20090917. Calcium channel blockers and angiotensin-converting enzyme inhibitors may be associated with altered atherosclerotic plaque size and morphology. : Vascular.

Harvard

Eagleton M. J., Bishop P. D., Bena J. F., Nassoiy S. P., Clair D. G., Kashyap V. S. and Ouriel K. (20090917). Calcium channel blockers and angiotensin-converting enzyme inhibitors may be associated with altered atherosclerotic plaque size and morphology. : Vascular.

MLA

Eagleton Matthew J, Bishop Paul D, Bena James F, Nassoiy Sean P, Clair Daniel G, Kashyap Vikram S and Ouriel Kenneth. Calcium channel blockers and angiotensin-converting enzyme inhibitors may be associated with altered atherosclerotic plaque size and morphology. : Vascular. 20090917.